ClearPoint Neuro (CLPT) Total Current Liabilities (2011 - 2026)

ClearPoint Neuro has disclosed Total Current Liabilities across 16 years of filings, most recently posting $9.5 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $9.5 million, up 38.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.5 million (up 38.07% YoY), and the FY2025 annual result was $10.8 million, up 3.98% from the prior year.
• Total Current Liabilities came in at $9.5 million for Q1 2026 at ClearPoint Neuro, down from $10.8 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $16.7 million in Q2 2024 to a low of $4.0 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $7.4 million (2025), against an average of $8.2 million.
• Across the five-year window, Total Current Liabilities surged 169.17% in 2024 and sank 55.68% in 2025, its largest moves.
• ClearPoint Neuro's Total Current Liabilities stood at $6.8 million in 2022, then increased by 9.46% to $7.4 million in 2023, then soared by 39.34% to $10.4 million in 2024, then grew by 3.98% to $10.8 million in 2025, then slipped by 11.94% to $9.5 million in 2026.
• The last three Total Current Liabilities figures came in at $9.5 million (Q1 2026), $10.8 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.